SLFN11 and small cell lung carcinoma: Moreover, expression of schlafen family member 11 (SLFN11), which promotes cell death following DNA damage, has been recently indicated as a biomarker of responsiveness in terms of PFS and OS in relapsed or refractory SCLC patients treated with temozolomide and the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib [44].